Cadrenal Therapeutics (CVKD) vs Silexion Therapeutics (SLXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.2 million vs $3.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | SLXN |
|---|---|---|
| Share price | $0.9101 | $0.2146 |
| Market cap | $3.25M | $3.11M |
| 1-day change | -2.10% | -8.64% |
| EPS (TTM) | $-4.91 | $-27.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $40.70 |
| 52-week low | $0.85 | $0.2079 |
| Distance from 52-week high | -93.72% | -99.47% |
| Analyst consensus | none | none |
| Avg. price target upside | +1438.29% | +2229.92% |
| Average volume | 458.82K | 9.90M |
| Shares outstanding | 3.57M | 14.47M |
| Employees | 5 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
CVKD vs SLXN FAQ
Which is bigger, Cadrenal Therapeutics or Silexion Therapeutics?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.25M compared with $3.11M for Silexion Therapeutics (SLXN).
Are Cadrenal Therapeutics and Silexion Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Cadrenal Therapeutics and Biotechnology: Biological Products (No Diagnostic Substances) for Silexion Therapeutics.